We assessed this using a two-sample MR analysis in men and found evidence supporting a causal relationship between gout inflammation (two of the three positively association variants were in loci encoding genes central to IL-1β signaling) and prostate cancer. This evidence concerns the gene IL1B and prostate carcinoma.